Dolutegravir Plus Lamivudine Maintains Human Immunodeficiency Virus-1 Suppression Through Week 48 in a Pilot Randomized Trial
Babafemi O Taiwo, Vincent C Marconi, Baiba Berzins, Carlee B Moser, Amesika N Nyaku, Carl J Fichtenbaum, Constance A Benson, Timothy Wilkin, Susan L Koletar, Jonathan Colasanti, Edward P Acosta, Jonathan Z Li, Paul E Sax, Babafemi O Taiwo, Vincent C Marconi, Baiba Berzins, Carlee B Moser, Amesika N Nyaku, Carl J Fichtenbaum, Constance A Benson, Timothy Wilkin, Susan L Koletar, Jonathan Colasanti, Edward P Acosta, Jonathan Z Li, Paul E Sax
Abstract
Source: PubMed